Abobotulinumtoxin A (Espad Pharmed)

N/A

Report date: 2025/05/27 20:00:07

Base Information

Drug NameAbobotulinumtoxin A (Espad Pharmed)
Drug Alias NameN/A
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsGlabellar lines
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIran
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEspad Pharmed
China Registration ClassN/A

Develop Information

Active CompaniesEspad Pharmed
Inactive CompaniesN/A
Active IndicationsGlabellar lines
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A